IMPROVEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPS

Recombinant human serum albumin (OsrHSA) has emerged as an important innovation in the field of biopharmaceuticals, presenting promising developments across various healthcare and industrial apps. With its structural similarity to Normally derived human serum albumin, OsrHSA gives a safer, additional dependable option for therapeutic use, notably i